XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated statements of changes in equity
USD ($)
$ / shares
shares
Peridot Acquisition Corp.
USD ($)
shares
Stock options
USD ($)
Restricted share units
USD ($)
Series C Shares
USD ($)
Share capital
USD ($)
shares
Share capital
Restricted share units
USD ($)
shares
Share capital
Series C Shares
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Stock options
USD ($)
Contributed surplus
Restricted share units
USD ($)
Accumulated deficit
USD ($)
Accumulated other comprehensive income (loss)
USD ($)
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2020 | shares           83,361,291              
Shareholders' equity, beginning balance at Oct. 31, 2020 $ 1,440,730         $ 15,441,600     $ 824,683     $ (14,528,941) $ (296,612)
Changes in equity [abstract]                          
Stock option expense 2,877,691   $ 141,228           2,877,691 $ 141,228      
Share issuance (in shares) | shares               11,220,218          
Share issuance         $ 21,620,000     $ 21,620,000          
Shares issued for non-cash costs (in shares) | shares           478,920              
Equity issued for non-cash costs 0         $ 455,055     (455,055)        
Comprehensive loss (6,845,323)                     (6,845,323)  
Shareholders' equity, ending balance (in shares) at Jan. 31, 2021 | shares           95,060,429              
Shareholders' equity, ending balance at Jan. 31, 2021 16,356,635         $ 37,516,655     510,856     (21,374,264) (296,612)
Changes in equity [abstract]                          
Warrant liability   $ 82,109,334                      
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2021 | shares           163,179,655              
Shareholders' equity, beginning balance at Oct. 31, 2021 $ 433,721,034         $ 672,079,154     3,026,721     (241,088,229) (296,612)
Changes in equity [abstract]                          
Exercise of warrants (in shares) | shares (22,540,651)         5,712,222              
Exercise of warrants $ 46,001,223         $ 46,001,223     0        
Restricted Share Units settled in shares (in shares) | shares             0            
Restricted Share Units settled in shares       $ 2,321,118     $ 0       $ 2,321,118    
Comprehensive loss 28,546,640                     28,546,640 0
Shareholders' equity, ending balance (in shares) at Jan. 31, 2022 | shares           168,891,877              
Shareholders' equity, ending balance at Jan. 31, 2022 $ 513,467,706         $ 718,080,377     8,225,530     (212,541,589) (296,612)
Changes in equity [abstract]                          
Exercise price of warrants (in dollars per share) | $ / shares $ 11.5                        
Redemption price of warrants (in dollars per share) | $ / shares $ 0.1                        
Shareholders' equity, ending balance (in shares) at Jan. 31, 2022 | shares           168,891,877              
Shareholders' equity, ending balance at Jan. 31, 2022 $ 513,467,706         $ 718,080,377     $ 8,225,530     $ (212,541,589) $ (296,612)
Changes in equity [abstract]                          
Number of warrants assumed in acquisition (in shares) | shares   0                      
Warrant liability   $ 0